The pathology associated with therapeutic procedures in malignant mesothelioma

Histopathology

Volumn 45, Issue 4, 2004, Pages 393-397

  Attanoos, R L ^a   Gibbs, A R ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Malignant mesothelioma; Therapy; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; ASBESTOS; MINERAL; TALC;

ARTICLE; ASBESTOS BODY; AUTOPSY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CELL PROLIFERATION; CLINICAL ARTICLE; CYTODIAGNOSIS; DIAGNOSTIC ERROR; FIBROBLAST; FOREIGN BODY REACTION; GIANT CELL; HUMAN; HUMAN TISSUE; IATROGENIC DISEASE; IMMUNOPHENOTYPING; INFLAMMATION; MELANOMA; MITOSIS RATE; MULTINUCLEAR CELL; PLEURA BIOPSY; PLEURA MESOTHELIOMA; PLEURODESIS; PLEUROPNEUMONECTOMY; PRIORITY JOURNAL; SARCOMA; THORAX WALL TUMOR; TRANSMISSION ELECTRON MICROSCOPY; TUMOR IMMUNOLOGY; TUMOR NECROSIS; WOUND;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IATROGENIC DISEASE; MESOTHELIOMA; PLEURAL NEOPLASMS; PLEURODESIS; RADIOTHERAPY; TALC; TREATMENT OUTCOME;

EID: 7244258775     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01928.x     Document Type: Article

References (11)

1. Rusch VV, Venkatraman S. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann. Thorac. Surg. 1999; 68; 1799-1804.
2. Hillerdal G. Malignant mesothelioma: review of 4710 published cases. Br. J. Dis. Chest 1983; 77; 321-343.
3. Boutin C, Schlesser M, Frenay C, Asoul P, Advances in the treatment of malignant pleural mesothelioma. Chest 1999; 116; 504-520.
4. Sterman DH, Kaiser L, Albelda SM. Advances in the treatment of malignant pleural mesothelioma. Chest 1999; 116; 504-520.
5. Mitha R., Pooley FD. Determination of asbestos in lung tissue using a T.E.M. in environmental carcinogens: methods of analysis and exposure measurement. Vol. 12. Indoor air. Scientific Publication no. 109. Feifart B, Van De Wiel J eds. Lyons: IARC, 1993.
6. Attanoos K, Gibbs AR. Pathology of malignant mesothelioma. Histopathology 1997; 30; 403-418.
7. Antony VB, Loddenkemper R, Astoul P et al. Management of malignant pleural effusions. Am. J. Respir. Crit. Care Med. 2000; 162; 1987-2001.
8. Churg A, Warnock ML. Asbestos and other ferruginous bodies. Am. J. Pathol. 1981; 102; 447-456.
9. Gibbs AR, Pooley FD, Griffiths DM et al. Talc pneumoconiosis: a pathologic and mineralogic study. Hum. Pathol. 1992; 23; 1344-1354.
10. Ng WK. Radiation-associated changes in tissue and tumours. Curr. Diagn. Pathol. 2003; 9; 124-136.
11. Chan JKC. Chemotherapy- and hormone-induced histologic changes in tumour. Curr. Diagn. Pathol. 2003; 9; 137-147.